---
title: Fetal Cardiac Magnetic Resonance in Detection of CHD
nct_id: NCT05066399
overall_status: UNKNOWN
sponsor: University Hospital, Bonn
study_type: OBSERVATIONAL
primary_condition: Congenital Heart Disease
countries: Germany
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05066399.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05066399"
ct_last_update_post_date: 2021-10-04
last_seen_at: "2026-05-12T07:24:32.713Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Fetal Cardiac Magnetic Resonance in Detection of CHD

**Official Title:** Fetal Cardiac Magnetic Resonance Imaging Using DUS Gating on 3T: Preliminary Experiences in Detection of CHD

**NCT ID:** [NCT05066399](https://clinicaltrials.gov/study/NCT05066399)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 100
- **Lead Sponsor:** University Hospital, Bonn
- **Conditions:** Congenital Heart Disease, Fetal Cardiac Disorder, Heart Defect, Congenital
- **Start Date:** 2021-05-11
- **Completion Date:** 2023-09
- **CT.gov Last Update:** 2021-10-04

## Brief Summary

The aim of this clinical prospective study is to investigate the value of fetal cardiac magnetic resonance imaging using a new Doppler ultrasound based gating method for the detection of congenital heart desease.

## Eligibility

- **Sex:** FEMALE
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* fetuses in third trimenon
* congenital heart defect suspected by obstetric ultrasound

Exclusion Criteria:

* pregnant women with contraindication for native MRI
```

## Primary Outcomes

- **The number of heart defect characteristics detectable by DUS gated Cine MRI imaging** _(time frame: Up to 3 months after birth, cardiac MRI findings will be compared against fetal ultrasound gainst fetal ultrasounand against findings after birth (reference standard).)_ — DUS gated Cine imaging will be applied to detect characteristics of clinically suspected congenital heart defects.

## Locations (1)

- University Hospital Bonn, Clinic for Diagnostic and Interventional Radiology, Bonn, North Rhine-Westphalia, Germany — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.university hospital bonn, clinic for diagnostic and interventional radiology|bonn|north rhine-westphalia|germany` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05066399.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05066399*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*